Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking. 
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
LAS VEGAS, Jan. 12, 2016 (GLOBE NEWSWIRE) -- Miracle Flights, previously known as "Miracle Flights for Kids" or "Angel Planes," is seeking to reconnect with patients and families that flew with the organization prior to 2011.
The organization hopes to connect for the purpose of obtaining updates on past flight recipients, including current medical status, major life events, education, career, hobbies, passions, etc. Updated stories may be utilized as testimonials and/or for an upcoming PBS special on Miracle Flights. Recording will take place at the Miracle Flights headquarters in March, and some recipients may be asked to participate in the project. Former patients not interested in appearing publically are still encouraged to submit an update for archival purposes.
Those interested in connecting are encouraged to contact:
Charles Courtney
Director of Special Projects
[email protected]
702-261-0494
CONTACT: Charles Courtney
Director of Special Projects
[email protected]
702-261-0494
